134 related articles for article (PubMed ID: 8888658)
21. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke.
Johansson L; Jansson JH; Boman K; Nilsson TK; Stegmayr B; Hallmans G
Stroke; 2000 Jan; 31(1):26-32. PubMed ID: 10625711
[TBL] [Abstract][Full Text] [Related]
22. The influence of weight loss on fibrinolytic and metabolic parameters in obese children and adolescents.
Sudi KM; Gallistl S; Tröbinger M; Payerl D; Weinhandl G; Muntean W; Aigner R; Borkenstein MH
J Pediatr Endocrinol Metab; 2001 Jan; 14(1):85-94. PubMed ID: 11220710
[TBL] [Abstract][Full Text] [Related]
23. Plasminogen activator inhibitor and the risk of cardiovascular disease: The Framingham Heart Study.
Tofler GH; Massaro J; O'Donnell CJ; Wilson PWF; Vasan RS; Sutherland PA; Meigs JB; Levy D; D'Agostino RB
Thromb Res; 2016 Apr; 140():30-35. PubMed ID: 26896607
[TBL] [Abstract][Full Text] [Related]
24. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
25. Diurnal changes of fibrinolysis in patients with liver cirrhosis and esophageal varices.
Piscaglia F; Siringo S; Hermida RC; Legnani C; Valgimigli M; Donati G; Palareti G; Gramantieri L; Gaiani S; Burroughs AK; Bolondi L
Hepatology; 2000 Feb; 31(2):349-57. PubMed ID: 10655257
[TBL] [Abstract][Full Text] [Related]
26. Association of sex hormones and adiposity with plasma levels of fibrinogen and PAI-1 in postmenopausal women.
Meilahn EN; Cauley JA; Tracy RP; Macy EO; Gutai JP; Kuller LH
Am J Epidemiol; 1996 Jan; 143(2):159-66. PubMed ID: 8546117
[TBL] [Abstract][Full Text] [Related]
27. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
[TBL] [Abstract][Full Text] [Related]
28. Effects of exercise intensity, duration, and time of day on fibrinolytic activity in physically active men.
Szymanski LM; Pate RR
Med Sci Sports Exerc; 1994 Sep; 26(9):1102-8. PubMed ID: 7808243
[TBL] [Abstract][Full Text] [Related]
29. Defective fibrinolysis occurs after infrainguinal reconstruction.
Killewich LA; Macko RF; Gardner AW; Cox K; Lilly MP; Flinn WR
J Vasc Surg; 1997 May; 25(5):858-64; discussion 865. PubMed ID: 9152313
[TBL] [Abstract][Full Text] [Related]
30. Effects of androgens on haemostasis.
Winkler UH
Maturitas; 1996 Jul; 24(3):147-55. PubMed ID: 8844628
[TBL] [Abstract][Full Text] [Related]
31. Leptin levels are not affected by enalapril treatment after an uncomplicated myocardial infarction, but associate strongly with changes in fibrinolytic variables in men.
Eriksson MA; Söderberg S; Nilsson TK; Eriksson M; Boman K; Jansson JH
Scand J Clin Lab Invest; 2020 Jul; 80(4):303-308. PubMed ID: 32125188
[TBL] [Abstract][Full Text] [Related]
32. Gemfibrozil treatment of combined hyperlipoproteinemia. No improvement of fibrinolysis despite marked reduction of plasma triglyceride levels.
Bröijersen A; Eriksson M; Wiman B; Angelin B; Hjemdahl P
Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):511-6. PubMed ID: 8624772
[TBL] [Abstract][Full Text] [Related]
33. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 levels in acute myocardial infarction.
Ganti AK; Potti A; Yegnanarayan R
Pathophysiol Haemost Thromb; 2002; 32(2):80-4. PubMed ID: 12214153
[TBL] [Abstract][Full Text] [Related]
34. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations].
Rabijewski M; Zgliczyński W
Endokrynol Pol; 2007; 58(3):213-9. PubMed ID: 17940987
[TBL] [Abstract][Full Text] [Related]
35. Comparative effects of pulsatile and nonpulsatile flow on plasma fibrinolytic balance in pediatric patients undergoing cardiopulmonary bypass.
Aĝirbaşli MA; Song J; Lei F; Wang S; Kunselman AR; Clark JB; Myers JL; Ündar A
Artif Organs; 2014 Jan; 38(1):28-33. PubMed ID: 24237252
[TBL] [Abstract][Full Text] [Related]
36. Acute psychological stress decreases plasma tissue plasminogen activator (tPA) and tissue plasminogen activator/plasminogen activator inhibitor-1 (tPA/PAI-1) complexes in cardiac patients.
Hevey D; McGee HM; Fitzgerald D; Horgan JH
Eur J Appl Physiol; 2000 Nov; 83(4 -5):344-8. PubMed ID: 11138573
[TBL] [Abstract][Full Text] [Related]
37. Fibrinolytic gene polymorphism and ischemic stroke.
Jood K; Ladenvall P; Tjärnlund-Wolf A; Ladenvall C; Andersson M; Nilsson S; Blomstrand C; Jern C
Stroke; 2005 Oct; 36(10):2077-81. PubMed ID: 16179568
[TBL] [Abstract][Full Text] [Related]
38. The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors.
Skouby SO; Sidelmann JJ; Nilas L; Gram J; Jespersen J
Climacteric; 2008; 11(6):489-97. PubMed ID: 18991076
[TBL] [Abstract][Full Text] [Related]
39. Prospective randomized study of effects of unopposed estrogen replacement therapy on markers of coagulation and inflammation in postmenopausal women.
Luyer MD; Khosla S; Owen WG; Miller VM
J Clin Endocrinol Metab; 2001 Aug; 86(8):3629-34. PubMed ID: 11502788
[TBL] [Abstract][Full Text] [Related]
40. Hormone replacement therapy in healthy postmenopausal women: a randomized, placebo-controlled study of effects on coagulation and fibrinolytic factors.
Gottsäter A; Rendell M; Hulthén UL; Berntorp E; Mattiasson I
J Intern Med; 2001 Mar; 249(3):237-46. PubMed ID: 11285043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
